您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报 (医学版) ›› 2022, Vol. 60 ›› Issue (11): 23-27.doi: 10.6040/j.issn.1671-7554.0.2022.0978

• 胸外科肺癌、食管癌微创诊治和加速康复专题 • 上一篇    下一篇

微创袖式肺叶切除手术：免疫治疗时代的机遇和挑战

高会江,魏煜程*()   

  1. 青岛大学附属医院胸外科, 山东 青岛 266003
  • 收稿日期:2022-08-18 出版日期:2022-11-01 发布日期:2022-11-04
  • 通讯作者: 魏煜程 E-mail:weiyuchengchest@163.com
  • 作者简介:魏煜程，主任医师，医学博士，硕士研究生导师。青岛大学附属医院胸外科副主任，西海岸院区胸外科主任。担任中国抗癌协会纵隔肿瘤专业委员会常委，中国老年保健协会肺癌专业委员会常委，山东省中青年肺癌联盟副主任委员，山东省临床肿瘤学会食管癌专家委员会副主任委员，青岛市抗癌协会胸部肿瘤专业委员会主任委员，MEDIASTINUM杂志编委。长期致力于胸部肿瘤的微创手术治疗及复杂局部晚期胸部肿瘤的外科手术及综合治疗。2012年受邀参加英国皇家外科学院举行的欧洲腔镜肺叶切除20周年纪念大会，做大会发言，获“Master of Thoracic Surgery”称号。以第一作者及通讯作者在《Annals of Thoracic Surgery》《Journal of Thoracic Disease》《Thoracic Cancer》及《中华外科杂志》《中华胸心外科杂志》《中国肺癌杂志》等专业学术期刊发表论文20余篇，累计影响因子30余分。培养硕士研究生20余人
  • 基金资助:
    青岛大学附属医院青年基金(QDFYQN 202101013)

Minimally invasive sleeve lobectomy: opportunities and challenges in the era of immunotherapy

Huijiang GAO,Yucheng WEI*()   

  1. Department of Thoracic Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266003, Shandong, China
  • Received:2022-08-18 Online:2022-11-01 Published:2022-11-04
  • Contact: Yucheng WEI E-mail:weiyuchengchest@163.com

RichHTML

0

PDF (PC)

14

摘要：

袖式肺叶切除手术是局部晚期可切除中央型肺癌的一种标准治疗方式。与全肺切除手术相比，袖式肺叶切除手术可以在不影响患者生存的前提下，最大限度地通过保留肺组织而改善患者的生活质量。尽管支气管袖式肺叶切除增加了手术难度，但随着胸腔镜以及机器人技术的发展，微创袖式肺叶切除手术已经成为胸外科的常规术式。目前，随着免疫治疗在肺癌新辅助以及诱导治疗领域中的研究进展，越来越多的局部晚期可切除或潜在可切除的肺癌通过免疫治疗获得了根治的机会，这在改善患者预后的同时也为胸外科微创手术，尤其是微创袖式肺叶切除手术提出了更高的要求。本文对微创袖式肺叶切除手术的现状进行系统阐述以及前景展望。

关键词: 中央型肺癌, 微创, 袖式肺叶切除, 免疫治疗, 生存

Abstract:

Sleeve lobectomy, as a standard treatment for locally advanced resectable central lung cancer, can maximize the preservation of lung tissue and improve patients' quality of life without affecting survival, compared with total pneumonectomy. With the development of thoracoscopic and robotic technology, minimally invasive sleeve lobectomy has become a routine procedure in thoracic surgery, although bronchial sleeve lobectomy has increased the difficulty of operation. At present, with the development of immunotherapy in the field of neoadjuvant and induction therapy for lung cancer, a growing number of locally advanced resectable or potentially resectable lung cancer has been treated with immunotherapy. This not only improves the prognosis of patients, but also puts forward higher requirements for minimally invasive thoracic surgery, especially minimally invasive sleeve lobectomy. In this paper, the current situation of minimally invasive sleeve lobectomy is systematically described and the prospect is prospected.

Key words: Centrally-located lung cancer, Minimally invasive, Sleeve lobectomy, Immunotherapy, Survival

中图分类号: 

  • R734.2
1 Siegel RL , Miller KD , Fuchs HE , et al. Cancer statistics, 2022[J]. CA Cancer J Clin, 2022, 72 (1): 7- 33.
doi: 10.3322/caac.21708
2 Xia C , Dong X , Li H , et al. Cancer statistics in china and united states, 2022: profiles, trends, and determinants[J]. Chin Med J (Engl), 2022, 135 (5): 584- 590.
doi: 10.1097/CM9.0000000000002108
3 Paulson DL , Shaw RR . Preservation of lung tissue by means of bronchoplastic procedures[J]. Am J Surg, 1955, 89 (2): 347- 355.
doi: 10.1016/0002-9610(55)90074-X
4 Tedder M , Anstadt MP , Tedder SD , et al. Current morbidity, mortality, and survival after bronchoplastic procedures for malignancy[J]. Ann Thorac Surg, 1992, 54 (2): 387- 391.
doi: 10.1016/0003-4975(92)91413-4
5 Abdelsattar ZM , Shen KR , Yendamuri S , et al. Outcomes after sleeve lung resections versus pneumonectomy in the united states[J]. Ann Thorac Surg, 2017, 104 (5): 1656- 1664.
doi: 10.1016/j.athoracsur.2017.05.086
6 Li Z , Chen W , Xia M , et al. Sleeve lobectomy compared with pneumonectomy for operable centrally located non-small cell lung cancer: a meta-analysis[J]. Transl Lung Cancer Res, 2019, 8 (6): 775- 786.
doi: 10.21037/tlcr.2019.10.11
7 Merritt RE , Mathisen DJ , Wain JC , et al. Long-term results of sleeve lobectomy in the management of non-small cell lung carcinoma and low-grade neoplasms[J]. Ann Thorac Surg, 2009, 88 (5): 1574- 1581.
doi: 10.1016/j.athoracsur.2009.07.060
8 Ludwig C , Stoelben E , Olschewski M , et al. Comparison of morbidity, 30-day mortality, and long-term survival after pneumonectomy and sleeve lobectomy for non-small cell lung carcinoma[J]. Ann Thorac Surg, 2005, 79 (3): 968- 973.
doi: 10.1016/j.athoracsur.2004.08.062
9 Kwon ST , Zhao L , Reddy RM , et al. Evaluation of acute and chronic pain outcomes after robotic, video-assisted thoracoscopic surgery, or open anatomic pulmonary resection[J]. J Thorac Cardiovasc Surg, 2017, 154 (2): 652- 659.
doi: 10.1016/j.jtcvs.2017.02.008
10 Bendixen M , Jorgensen OD , Kronborg C , et al. Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial[J]. Lancet Oncol, 2016, 17 (6): 836- 844.
doi: 10.1016/S1470-2045(16)00173-X
11 Yang HX , Woo KM , Sima CS , et al. Long-term survival based on the surgical approach to lobectomy for clinical stage Ⅰ nonsmall cell lung cancer: comparison of robotic, video-assisted thoracic surgery, and thoracotomy lobectomy[J]. Ann Surg, 2017, 265 (2): 431- 437.
doi: 10.1097/SLA.0000000000001708
12 潘茂杰, 高会江, 蒋志慧, 等. 基于倾向性评分匹配法的胸腔镜与开放袖式肺叶切除术近期与远期疗效比较[J]. 中华外科杂志, 2018, 56 (7): 533- 537.
13 Gao HJ , Jiang ZH , Gong L , et al. Video-assisted vs thoracotomy sleeve lobectomy for lung cancer: a propensity matched analysis[J]. Ann Thorac Surg, 2019, 108 (4): 1072- 1079.
doi: 10.1016/j.athoracsur.2019.04.037
14 Zhang C , Ma Y , Yu Z , et al. Comparison of efficacy and safety of hybrid video-assisted thoracoscopic surgery vs. thoracotomy sleeve lobectomy for non-small cell lung cancer: a propensity score matching study[J]. J Thorac Dis, 2022, 14 (7): 2635- 2644.
doi: 10.21037/jtd-22-754
15 Yang Y , Mei J , Lin F , et al. Comparison of the short- and long-term outcomes of video-assisted thoracoscopic surgery versus open thoracotomy bronchial sleeve lobectomy for central lung cancer: a retrospective propensity score matched cohort study[J]. Ann Surg Oncol, 2020, 27 (11): 4384- 4393.
doi: 10.1245/s10434-020-08805-y
16 Xie D , Deng J , Gonzalez-Rivas D , et al. Comparison of video-assisted thoracoscopic surgery with thoracotomy in bronchial sleeve lobectomy for centrally located non-small cell lung cancer[J]. J Thorac Cardiovasc Surg, 2021, 161 (2): 403- 413.e2.
doi: 10.1016/j.jtcvs.2020.01.105
17 Ettinger DS , Wood DE , Aisner DL , et al. Non-small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2022, 20 (5): 497- 530.
doi: 10.6004/jnccn.2022.0025
18 Provencio M , Serna-Blasco R , Nadal E , et al. Overall survival and biomarker analysis of neoadjuvant nivolumab plus chemotherapy in operable stage ⅢA non-small-cell lung cancer (NADIM phase Ⅱ trial)[J]. J Clin Oncol, 2022, 40 (25): 2924- 2933.
doi: 10.1200/JCO.21.02660
19 Sierra-Rodero B , Cruz-Bermudez A , Nadal E , et al. Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial[J]. J Immunother Cancer, 2021, 9 (8): e002804.
doi: 10.1136/jitc-2021-002804
20 Provencio M , Nadal E , Insa A , et al. Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial[J]. Lancet Oncol, 2020, 21 (11): 1413- 1422.
doi: 10.1016/S1470-2045(20)30453-8
21 Forde PM , Spicer J , Lu S , et al. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer[J]. N Engl J Med, 2022, 386 (21): 1973- 1985.
doi: 10.1056/NEJMoa2202170
22 Deng H , Liu J , Cai X , et al. Radical minimally invasive surgery after immuno-chemotherapy in initially-unresectable stage ⅢB non-small cell lung cancer[J]. Ann Surg, 2022, 275 (3): e600- e602.
doi: 10.1097/SLA.0000000000005233
23 Liang H , Yang C , Gonzalez-Rivas D , et al. Sleeve lobectomy after neoadjuvant chemoimmunotherapy/chemotherapy for local advanced non-small cell lung cancer[J]. Transl Lung Cancer Res, 2021, 10 (1): 143- 155.
doi: 10.21037/tlcr-20-778
24 Petersen RH , Hansen HJ . Learning curve associated with VATS lobectomy[J]. Ann Cardiothorac Surg, 2012, 1 (1): 47- 50.
25 Rendina EA , Venuta F , Ricci P , et al. Protection and revascularization of bronchial anastomoses by the intercostal pedicle flap[J]. J Thorac Cardiovasc Surg, 1994, 107 (5): 1251- 1254.
doi: 10.1016/S0022-5223(94)70045-1
26 Storelli E , Tutic M , Kestenholz P , et al. Sleeve resections with unprotected bronchial anastomoses are safe even after neoadjuvant therapy[J]. Eur J Cardiothorac Surg, 2012, 42 (1): 77- 81.
doi: 10.1093/ejcts/ezr291
27 Lewis RJ , Caccavale RJ , Sisler GE , et al. One hundred consecutive patients undergoing video-assisted thoracic operations[J]. Ann Thorac Surg, 1992, 54 (3): 421- 426.
doi: 10.1016/0003-4975(92)90431-3
28 Santambrogio L , Cioffi U , De Simone M , et al. Video-assisted sleeve lobectomy for mucoepidermoid carcinoma of the left lower lobar bronchus: a case report[J]. Chest, 2002, 121 (2): 635- 636.
doi: 10.1378/chest.121.2.635
29 Mahtabifard A , Fuller CB , McKenna RJ Jr . Video-assisted thoracic surgery sleeve lobectomy: a case series[J]. Ann Thorac Surg, 2008, 85 (2): S729- 732.
doi: 10.1016/j.athoracsur.2007.12.001
30 Schmid T , Augustin F , Kainz G , et al. Hybrid video-assisted thoracic surgery-robotic minimally invasive right upper lobe sleeve lobectomy[J]. Ann Thorac Surg, 2011, 91 (6): 1961- 1965.
doi: 10.1016/j.athoracsur.2010.08.079
31 Gu C , Pan X , Chen Y , et al. Short-term and mid-term survival in bronchial sleeve resection by robotic system versus thoracotomy for centrally located lung cancer[J]. Eur J Cardiothorac Surg, 2018, 53 (3): 648- 655.
doi: 10.1093/ejcts/ezx355
32 Gonzalez-Rivas D , Fernandez R , Fieira E , et al. Uniportal video-assisted thoracoscopic bronchial sleeve lobectomy: first report[J]. J Thorac Cardiovasc Surg, 2013, 145 (6): 1676- 1677.
doi: 10.1016/j.jtcvs.2013.02.052
33 Gonzalez-Rivas D , Yang Y , Stupnik T , et al. Uniportal video-assisted thoracoscopic bronchovascular, tracheal and carinal sleeve resections[J]. Eur J Cardiothorac Surg, 2016, 49 (Suppl 1): i6- 16.
34 Cerfolio RJ . Robotic sleeve lobectomy: technical details and early results[J]. J Thorac Dis, 2016, 8 (Suppl 2): 223- 226.
35 Pan X , Gu C , Wang R , et al. Initial experience of robotic sleeve resection for lung cancer patients[J]. Ann Thorac Surg, 2016, 102 (6): 1892- 1897.
doi: 10.1016/j.athoracsur.2016.06.054
36 Zhong Y , Wang Y , Hu X , et al. A systematic review and meta-analysis of thoracoscopic versus thoracotomy sleeve lobectomy[J]. J Thorac Dis, 2020, 12 (10): 5678- 5690.
doi: 10.21037/jtd-20-1855
37 No authors listed . Neoadjuvant PD-1 blockade in resectable lung cancer; nivolumab and ipilimumab in advanced melanoma; overall survival with combined nivolumab and ipilimumab in advanced melanoma; prolonged survival in stage Ⅲ melanoma with ipilimumab adjuvant therapy; combined nivolumab and ipilimumab or monotherapy in untreated melanoma; combined nivolumab and ipilimumab or monotherapy in untreated melanoma; nivolumab and ipilimumab versus ipilimumab in untreated melanoma; rapid eradication of a bulky melanoma mass with one dose of immunotherapy; genetic basis for clinical response to ctla-4 blockade; genetic basis for clinical response to CTLA-4 blockade in melanoma; nivolumab plus ipilimumab in advanced melanoma; safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma; hepatotoxicity with combination of vemurafenib and ipilimumab[J]. N Engl J Med, 2018, 379 (22): 2185.
doi: 10.1056/NEJMx180040
38 Kim HK , Cho JH , Choi YS , et al. Outcomes of neoadjuvant concurrent chemoradiotherapy followed by surgery for non-small-cell lung cancer with N2 disease[J]. Lung Cancer, 2016, 96, 56- 62.
doi: 10.1016/j.lungcan.2016.03.016
39 Rendina EA , Venuta F , De Giacomo T , et al. Safety and efficacy of bronchovascular reconstruction after induction chemotherapy for lung cancer[J]. J Thorac Cardiovasc Surg, 1997, 114 (5): 830- 835.
doi: 10.1016/S0022-5223(97)70088-6
40 Chriqui LE , Forster C , Lovis A , et al. Is sleeve lobectomy safe after induction therapy a systematic review and meta-analysis[J]. J Thorac Dis, 2021, 13 (10): 5887- 5898.
doi: 10.21037/jtd-21-939
[1] 逄锦宏,苏萍,乔俊鹏,陈巧巧,陈学禹,赵颖颖,施婕,孙晓茹,李秋春,何蕊言,范轶欧,迟蔚蔚. 老年人群可改变心血管危险因素聚集模式与脑卒中的关联[J]. 山东大学学报 (医学版), 2025, 63(9): 11-19.
[2] 王磊,常霄,王梓萌,李娇娇,崔书君,杨飞,朱月香. 瘤内及瘤周DCE-MRI影像组学对宫颈癌患者无进展生存期的预测价值[J]. 山东大学学报 (医学版), 2025, 63(6): 45-54.
[3] 胡冰涛,张文灿,王崇怡,林翔宇,王凯斌,冯运泽,刘郴,徐万龙,李乐,司海朋. 基于加速康复外科理念的单孔分体内镜微创技术治疗腰椎管狭窄症的临床效果分析[J]. 山东大学学报 (医学版), 2025, 63(3): 1-7.
[4] 郭浩男,周鹏,李小磊,岳涛,徐婧,邵长秀,贺青卿,庄大勇. 甲状旁腺全切术与甲状旁腺全切术+微量自体移植术治疗继发性甲状旁腺功能亢进的疗效对照[J]. 山东大学学报 (医学版), 2024, 62(12): 72-81.
[5] 吕龙飞,李继如,翟允鹏,赵华善,郭锐,许洪修,黄赛,张士松. 单术者双孔法在电视辅助胸腔镜手术治疗儿童叶外型肺隔离症中的早期临床应用[J]. 山东大学学报 (医学版), 2024, 62(1): 57-62.
[6] 宋兆录,董正璇,彭传真,黄彩娜,胡克清,黄永胜,阎磊. 肾透明细胞癌中预后相关RNA编辑位点的筛选[J]. 山东大学学报 (医学版), 2023, 61(9): 69-78.
[7] 刘昶,王倩男,张悦,陈忠绍,褚然,姚舒. 卵巢交界性肿瘤保留生育功能术后肿瘤预后及妊娠结局[J]. 山东大学学报 (医学版), 2023, 61(8): 61-66.
[8] 卢伟,刘欢,贾贤杰,苏萍,施婕,王雅倩,迟蔚蔚. 植被覆盖与呼吸系统恶性肿瘤死亡风险关联分析[J]. 山东大学学报 (医学版), 2023, 61(8): 94-100.
[9] 蔡强,单悌超,吴晗. 临终病情评估单预测临终患者生存期的效果[J]. 山东大学学报 (医学版), 2023, 61(5): 79-83.
[10] 胡立勇,钟浩,房娟娟,国巍,张雨露,范医东. 基于数据库分析CCR基因对肾透明细胞癌预后的预测价值[J]. 山东大学学报 (医学版), 2023, 61(4): 49-55.
[11] 乔桦,李慧武. 膝关节置换手术机器人应用现状与研究进展[J]. 山东大学学报 (医学版), 2023, 61(3): 29-36.
[12] 张英晨,赵帅,孙浩,毕文浩,吴志强,成小建,蒋立城. 局麻下非同步CT辅助联合超声定位微创经皮肾镜取石术治疗上尿路结石的效果[J]. 山东大学学报 (医学版), 2023, 61(10): 46-50.
[13] 吴瑞芳,李长忠. 女性生育力保护的现状与进展[J]. 山东大学学报 (医学版), 2022, 60(9): 1-7.
[14] 高中霞,张铭,樊明德,谭晨阳,王梦迪,王超,樊跃飞,丁守銮,王成伟. 伽玛刀治疗81例肺癌脑转移瘤的疗效及预后因素[J]. 山东大学学报 (医学版), 2022, 60(8): 44-49.
[15] 秦静,杨飞,陈谦,夏涵岱,刘延国,王秀问. 晚期驱动基因阴性、PD-L1表达阴性非鳞非小细胞肺癌一线治疗方案的网状Meta分析[J]. 山东大学学报 (医学版), 2022, 60(7): 74-82.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发